Gesundheitswesen

Entscheidende Beratung auf Ihrem Weg

Mit neuen und bahnbrechenden Technologien, die den Status quo ständig hinterfragen, schreitet die Gesundheitsbranche sprunghaft voran. Aber in einer Branche, die auf Vorschriften basiert, sind strategische Partnerschaften oft der Schlüssel für eine erfolgreiche Geschäftsentwicklung.

Unsere leidenschaftlichen Berater, unterstützt von Subbranchenteams weltweit, nutzen ihr fundiertes Fachwissen, um Ihren Wettbewerbsvorteil zu finden, die lokalen Gewohnheiten zu verstehen und Ihnen bei der Entwicklung der am besten geeigneten Strategie zu unterstützen.

Ansprechpartner

Global

556

abgeschlossene Transaktionen in der Gesundheitswesen

Global

Informieren Sie sich über alle unsere branchenbezogenen Transaktionen

Zu den Deals

Banook, backed by Motion Equity, has acquired Fluidda

Gesundheitswesen | Technologie, Medien und Telekommunikation

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Weitere Informationen

Iason GmbH has continued its refinancing efforts with local banks based on an IBR

Gesundheitswesen

Iason GmbH has continued its refinancing efforts with local banks based on an IBR

The shareholders of Iason GmbH have completed a restructuring of the company and its refinancing efforts with local banks based on an IBR.

Weitere Informationen

Olyos Group has acquired a controlling stake in NewScience

Gesundheitswesen

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Weitere Informationen

„Oaklins’ efforts enabled us to join Banook and significantly enhance our impact on respiratory drug development. Together with an outstanding transaction team, we were able to efficiently integrate into the Banook platform, backed by Motion Equity Partners.“

Jan De Backer

CEO, Fluidda NV

Weitere Information

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Electronic medical device manufacturer secures buyer for two key subsidiaries in the US and Morocco

DEAL FLASH: Cicor Group has acquired the US and Moroccan subsidiaries of Valtronic. Through this transaction, Valtronic’s shareholders have secured the long-term development and success of the two entities, while Cicor gains access to the US market and doubles its production capacity in Morocco.

Weitere Informationen